Results 201 to 210 of about 30,077 (251)

Study of Hematological and Biochemical Markers Including Hepcidin in Chronic Kidney Disease Non-Dialysis-Dependent Patients

Harpreet Kaur Matharu, Priyanka Mandia, A.K. Verma, Rashmi Devanda   +3 more
openalex   +1 more source

Iron status, hepcidin, and CRP in children with endoscopically confirmed adenotonsillar hypertrophy: a controlled cross-sectional study. [PDF]

BMC Pediatr
Keskin S, Keskin N.
europepmc   +1 more source

Integrated Monitoring of Hepcidin, Inflammatory Markers and Heart Rate Variability in Endurance Athletes: Implications for Early Detection of Non-Functional Overreaching - A Narrative Review

Magdalena Kolasa, Natalia Kasterka, Liwia Karbownik, Agnieszka Figwer, Krzysztof Figwer, Kinga Dzitkowska, Norbert Czarny, Anna Broniecka, Michał Śmigielski, Jędrzej Garbaciak   +9 more
openalex   +2 more sources

Immunological response of goldfish (Carassius auratus) to recombinant pro-hepcidin and its antibacterial activity against Aeromonas hydrophila. [PDF]

BMC Vet Res
Gheisari M, Ghadikolaii FP, Khoshbakht R, Shohreh P, Kaboosi H.   +4 more
europepmc   +1 more source

Hepcidin Values in Pediatric Celiac Disease Patients and Their Relationships with Iron Parameters

Naim Uzun, Adem Keski̇n, Recai Acı, Melek Bilgin, Mahcube Çubukçu   +4 more
openalex   +1 more source

Halofuginone suppresses hepcidin by a heparan sulfate-dependent mechanism to treat iron disorders in mice. [PDF]

Blood Adv
Leal S, Denardo A, Van Echten A, Jungnickel H, Nelson CB, Sandoval D, Salvador JA, Shin J, Chung A, Brush MN, Bennett CP, Piermatteo A, Secrest PD, Jung CL, Ganz T, Poli M, Gordts PLSM.   +16 more
europepmc   +1 more source

Iron deficiency without anemia: An underrecognized and undertreated clinical condition with special focus on colorectal cancer. [PDF]

Clin Hematol Int
Raja NP, Kandagari N.
europepmc   +1 more source

BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva. [PDF]

JBMR Plus
Wang H, Toutounchi S, Pignolo RJ, Cheng X, Parker CD, Liu Q, Muppa S, Kellogg-Yelder D, Polach KJ, Kotian PL, Babu YS, Chen X.   +11 more
europepmc   +1 more source

Impact of oral iron dosing regimens on iron biomarkers during pregnancy: insights from the PANDA trial. [PDF]

Blood Adv
Haynes S, Armitage AE, Roy NBA, Morovat A, Drakesmith H, Churchill D, Stanworth SJ.   +6 more
europepmc   +1 more source

Relationships of high mean corpuscular volume, low total iron binding capacity and protein-energy wasting in patients on maintenance hemodialysis. [PDF]

Clin Exp Nephrol
Ikeda-Taniguchi M, Hirao K, Shibagaki K, Honda H.   +3 more
europepmc   +1 more source